日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors

同时抑制 IGF1R 和 ERK 可增加胰腺癌对自噬抑制剂的敏感性

Clint A Stalnecker, Kajal R Grover, A Cole Edwards, Michael F Coleman, Runying Yang, Jonathan M DeLiberty, Björn Papke, Craig M Goodwin, Mariaelena Pierobon, Emanuel F Petricoin, Prson Gautam, Krister Wennerberg, Adrienne D Cox, Channing J Der, Stephen D Hursting, Kirsten L Bryant

CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis

CIP2A 与 TopBP1 相互作用并驱动基底样乳腺癌的肿瘤发生

Laine, Anni; Nagelli, Srikar G; Farrington, Caroline; Butt, Umar; Cvrljevic, Anna N; Vainonen, Julia P; Feringa, Femke M; Grönroos, Tove J; Gautam, Prson; Khan, Sofia; Sihto, Harri; Qiao, Xi; Pavic, Karolina; Connolly, Denise C; Kronqvist, Pauliina; Elo, Laura L; Maurer, Jochen; Wennerberg, Krister; Medema, Rene H; Joensuu, Heikki; Peuhu, Emilia; de Visser, Karin; Narla, Goutham; Westermarck, Jukka

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations

针对患者量身定制的白血病细胞亚群选择性联合抑制设计

Aleksandr Ianevski, Jenni Lahtela, Komal K Javarappa, Philipp Sergeev, Bishwa R Ghimire, Prson Gautam, Markus Vähä-Koskela, Laura Turunen, Nora Linnavirta, Heikki Kuusanmäki, Mika Kontro, Kimmo Porkka, Caroline A Heckman, Pirkko Mattila, Krister Wennerberg, Anil K Giri, Tero Aittokallio

Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor

癌细胞系组学谱的多模态荟萃分析表明 ECHDC1 是一种新型乳腺肿瘤抑制因子

Alok Jaiswal, Prson Gautam, Elina A Pietilä, Sanna Timonen, Nora Nordström, Yevhen Akimov, Nina Sipari, Ziaurrehman Tanoli, Thomas Fleischer, Kaisa Lehti, Krister Wennerberg, Tero Aittokallio

Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

非典型 KRASG12R 突变体在胰腺癌中 PI3K 信号传导和巨胞饮作用受损

G Aaron Hobbs, Nicole M Baker, Anne M Miermont, Ryan D Thurman, Mariaelena Pierobon, Timothy H Tran, Andrew O Anderson, Andrew M Waters, J Nathaniel Diehl, Bjoern Papke, Richard G Hodge, Jennifer E Klomp, Craig M Goodwin, Jonathan M DeLiberty, Junning Wang, Raymond W S Ng, Prson Gautam, Kirsten L Br

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

低剂量垂直抑制 RAF-MEK-ERK 级联可导致 KRAS 突变癌细胞凋亡

Irem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, Antje Schaefer, Bjoern Papke, Kathleen Klotz-Noack, Andrew M Waters, Craig M Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S K Gilbert, Kevin H Lin, Onur Dagliyan, Krister Wennerberg, Emanuel F Petricoin 3rd, Nhan L Tran, Shripa

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening

标准化的药物反应指标可提高基于细胞筛选的抗癌药物敏感性定量分析的准确性和一致性。

Gupta, Abhishekh; Gautam, Prson; Wennerberg, Krister; Aittokallio, Tero

Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer.

利用高通量药物筛选技术系统地绘制三阴性乳腺癌细胞靶点依赖性图谱

Wang Tianduanyi, Gautam Prson, Rousu Juho, Aittokallio Tero

Multiobjective optimization identifies cancer-selective combination therapies

多目标优化可识别癌症选择性联合疗法

Pulkkinen, Otto I; Gautam, Prson; Mustonen, Ville; Aittokallio, Tero

Prediction of drug combination effects with a minimal set of experiments

通过最少的实验预测药物组合效应

Aleksandr Ianevski, Anil K Giri, Prson Gautam, Alexander Kononov, Swapnil Potdar, Jani Saarela, Krister Wennerberg, Tero Aittokallio